During the past decade, National Hospital Organization Kumamoto Medical Center conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 6 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 6 clinical trials were completed. i.e. 46.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Kumamoto Medical Center" #1 sponsor was "Pfizer" with 10 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Kyowa Kirin Co., Ltd." with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kumamoto Medical Center" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Asahi Kasei Medical Co., Ltd." with 1 trials as a collaborator and "Kyowa Kirin, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kumamoto Medical Center" are "Multiple Myeloma" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Prostate Cancer" (2 trials), "Abiraterone Acetate" (1 trials) and "Acute Kidney Injury Due to Sepsis" (1 trials). Many other conditions were trialed in "National Hospital Organization Kumamoto Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Kumamoto Medical Center" are "Drug" (26 trials), "Biological" (5 trials), "Other" (4 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Abemaciclib" (2 trials), "Bendamustine" (2 trials), "Best Supportive Care" (2 trials) and "Daratumumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Kumamoto Medical Center" are 27 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "National Hospital Organization Kumamoto Medical Center". undefined are not yet recruiting, 6 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in National Hospital Organization Kumamoto Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Kumamoto Medical Center, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".